Increases Dividend By 50% To SEK 6 After High Growth And Significant Improvement In Profitability.
Zinzino AB (publ) (ZZ-B.ST), a global direct-sales company, reports that revenue for the fourth quarter of 2025 amounted to SEK 1,035.3 (713.5) million, corresponding to 45% (35%) growth compared with the same period last year. In local currencies, revenue for the fourth quarter increased by 52% compared with the corresponding period last year. EBITDA rose to SEK 175.2 (72.9) million after the EBITDA margin increased to 16.9% (10.2%). The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies, primarily related to the acquisition of Zurvita.
During the quarter, Zinzino acquired 35% of the shares in Xion International Group with the aim of producing algae using bioreactors, thereby securing a sustainable future supply of omega-3 for the company’s main product, BalanceOil. In addition, the assets of the direct sales company Sanki were acquired to increase distribution power in North and South America, and the Gut Health Test was launched.
For the full year 2025, total revenue amounted to SEK 3,337.5 (2,207.8) million, corresponding to 51% (25%) growth compared with the previous year. EBITDA amounted to SEK 443.4 (250.7) million